Multiple myeloma with CD138 changed from positive to negative: A case report

被引:1
作者
Yu, Jianlin [1 ]
Tan, Liming [1 ]
Wu, Qiong [1 ]
Rao, Yanfei [1 ]
Ao, Jianyun [1 ]
Yang, Weiming [1 ]
Zou, Bei [1 ]
Chen, Juanjuan [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab, Jiangxi Prov Key Lab,Lab Med, Nanchang 330006, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
CD138; flow cytometry; multiple myeloma; CELLS; SURVIVAL;
D O I
10.1002/cyto.b.21869
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background Multiple myeloma (MM) is a common malignant disease of the blood system, caused by the neoplastic proliferation of plasma cells that accumulate in bone marrow (BM). Here, we report a case of MM patient with CD138 marker changed from positive to negative. Methods BM and peripheral blood samples from a 48-year-old patient with MM were examined and analyzed by conventional morphology, flow cytometry, and immunodetection. Results Imaging examination and clinical manifestations fulfilled criteria for MM. On the first hospitalization, flow cytometry showed that the cells were CD138(+)/CD38(+)/CD19(-)/CD56(+). However, on the fifth hospitalization, flow cytometry revealed that the cells were CD138(-)/CD38(+)/CD19(-)/CD56(+). Conclusions MM is diagnosed on imaging and clinical manifestations, immunophenotype of flow cytometry is also an important method of diagnosing MM. However, the discovery of atypical immunophenotypes cannot prevent the diagnosis of MM, even provide a clue of disease progression.
引用
收藏
页码:249 / 253
页数:5
相关论文
共 50 条
  • [31] Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders
    Bae, Jooeun
    Tai, Yu-Tzu
    Anderson, Kenneth C.
    Munshi, Nikhil C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 155 (03) : 349 - 361
  • [32] F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma
    Ak, Ilknur
    Gulbas, Zafer
    ANNALS OF HEMATOLOGY, 2011, 90 (01) : 81 - 87
  • [33] F-18 FDG uptake of bone marrow on PET/CT scan: it’s correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma
    İlknur Ak
    Zafer Gulbas
    Annals of Hematology, 2011, 90 : 81 - 87
  • [34] HRAS mutation positive multiple myeloma in the type 2 CALR mutation positive essential thrombocythemia: A case report
    Lewandowski, Krzysztof
    Agata, Kopydlowska
    Zuzanna, Kandula
    Sankowski, Bartlomiej
    Machnicki, Marcin
    Marta, Baranska
    Kinga, Gwozdz-Bak
    Tadeusz, Kubicki
    Anna, Plotka
    Lucja, Przysiecka
    Grzegorz, Dworacki
    Piotr, Kozlowski
    Tomasz, Stoklosa
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (02) : 299 - 303
  • [35] CD38-Negative Myeloma with Anaplastic Morphology at Presentation: A Case Report
    Singh, Neha
    Agrawal, Narendra
    Mehta, Anurag
    Panaych, Ajit
    Sekhri, Radhika
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (02) : 362 - 364
  • [36] Optimal strategy for obtaining routine chromosome analysis by using negative fractions of CD138 enriched plasma cells
    Ortega, Veronica
    Mohamed, Gihan
    Ehman, William, Jr.
    Zhu, Meiqing
    Mendiola, Christina
    Velagaleti, Gopalrao
    CANCER GENETICS, 2016, 209 (03) : 82 - 86
  • [37] Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma
    Sahara, N
    Takeshita, A
    Shigeno, K
    Fujisawa, S
    Takeshita, K
    Naito, K
    Ihara, M
    Ono, T
    Tamashima, S
    Nara, K
    Ohnishi, K
    Ohno, R
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 117 (04) : 882 - 885
  • [38] Hypoxia reduces CD138 expression and induces an immature and stem cell-like transcriptional program in myeloma cells
    Kawano, Yawara
    Kikukawa, Yoshitaka
    Fujiwara, Shiho
    Wada, Naoko
    Okuno, Yutaka
    Mitsuya, Hiroaki
    Hata, Hiroyuki
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2013, 43 (06) : 1809 - 1816
  • [39] Targeted therapy for multiple myeloma: an overview on CD138-based strategies
    Riccardi, Federico
    Tangredi, Carmela
    Dal Bo, Michele
    Toffoli, Giuseppe
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] Characterisation and relevance of CD138-negative plasma cells in plasma cell myeloma
    Reid, S.
    Yang, S.
    Brown, R.
    Kabani, K.
    Aklilu, E.
    Ho, P. J.
    Woodland, N.
    Joshua, D.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2010, 32 (06) : E190 - E196